|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2008-2-12
|
|
pubmed:abstractText |
Concentration-controlled everolimus with concomitant cyclosporine (CsA) dose reduction in renal transplantation permits preservation of kidney function without loss of efficacy. Data are lacking regarding everolimus with reduced-dose CsA in maintenance cardiac transplant patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1557-3117
|
|
pubmed:author |
pubmed-author:BurtonJeffrey RJR,
pubmed-author:CADENCE Study Group,
pubmed-author:CantarovichMarceloM,
pubmed-author:DorentRichardR,
pubmed-author:HaddadHaissamH,
pubmed-author:HowlettJonathanJ,
pubmed-author:IgnaszewskiAndrewA,
pubmed-author:PflugfelderPeterP,
pubmed-author:RossHeatherH,
pubmed-author:VaillancourtMarcM,
pubmed-author:WhiteMichaelM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
197-202
|
|
pubmed:meshHeading |
pubmed-meshheading:18267227-Adolescent,
pubmed-meshheading:18267227-Adult,
pubmed-meshheading:18267227-Aged,
pubmed-meshheading:18267227-Canada,
pubmed-meshheading:18267227-Confidence Intervals,
pubmed-meshheading:18267227-Cyclosporine,
pubmed-meshheading:18267227-Dose-Response Relationship, Drug,
pubmed-meshheading:18267227-Drug Administration Schedule,
pubmed-meshheading:18267227-Drug Therapy, Combination,
pubmed-meshheading:18267227-Female,
pubmed-meshheading:18267227-Graft Rejection,
pubmed-meshheading:18267227-Graft Survival,
pubmed-meshheading:18267227-Heart Transplantation,
pubmed-meshheading:18267227-Humans,
pubmed-meshheading:18267227-Immunosuppressive Agents,
pubmed-meshheading:18267227-Male,
pubmed-meshheading:18267227-Middle Aged,
pubmed-meshheading:18267227-Pilot Projects,
pubmed-meshheading:18267227-Risk Assessment,
pubmed-meshheading:18267227-Single-Blind Method,
pubmed-meshheading:18267227-Sirolimus,
pubmed-meshheading:18267227-Statistics, Nonparametric,
pubmed-meshheading:18267227-Survival Analysis,
pubmed-meshheading:18267227-Transplantation, Homologous,
pubmed-meshheading:18267227-Transplantation Immunology,
pubmed-meshheading:18267227-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Cyclosporine reduction in the presence of everolimus: 3-month data from a Canadian pilot study of maintenance cardiac allograft recipients.
|
|
pubmed:affiliation |
Department of Cardiology, Toronto General Hospital, Toronto, Ontario, Canada. heather.ross@uhn.on.ca
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
